Detection of acute HIV infection: We can't close the window

Journal of Infectious Diseases

Volumn 205, Issue 4, 2012, Pages 521-524

  Branson, Bernard M ^a   Stekler, Joanne D ^b,c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Public Health Seattle and King County HIV/STD Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS RNA;

ANTIBODY DETECTION; ANTIGEN ANTIBODY COMPLEX; ANTIGEN DETECTION; ENZYME IMMUNOASSAY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; INTERMETHOD COMPARISON; LATERAL FLOW TEST; LIMIT OF DETECTION; NOTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RNA ANALYSIS; SENSITIVITY ANALYSIS; SEROCONVERSION; VIRUS LOAD; VIRUS REPLICATION; WESTERN BLOTTING;

ANTI-HIV AGENTS; ANTIGENS, VIRAL; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CASE MANAGEMENT; CLINICAL LABORATORY TECHNIQUES; DIAGNOSTIC TESTS, ROUTINE; DISEASE TRANSMISSION, INFECTIOUS; DNA, VIRAL; DRUG RESISTANCE, VIRAL; FEMALE; GENES, POL; HIV; HIV ANTIBODIES; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOASSAY; MALE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POINT-OF-CARE SYSTEMS; RNA, VIRAL;

EID: 84856284032     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir793     Document Type: Note

References (31)

1. Kahn JO, Walker BD. Acute human immunodeficiency virus type 1 infection. N Engl J Med 1998; 339:33-9.
2. Hare CB, Kahn JO. Primary HIV infection. Curr Infect Dis Rep 2004; 6:65-71. (Pubitemid 39345319)
3. CLSI. Criteria for laboratory testing and diagnosis of human immunodeficiency virus infection; approved guideline. CLSI document M53-A. Wayne, PA: Clinical and Laboratory Standards Institute, 2011.
4. Rosenberg ES, Altfeld M, Poon SH, et al. Immune control ofHIV-1 after early treatment of acute infection. Nature 2000; 407:523-6.
5. Hecht FM, Wang L, Collier A, et al. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection. J Infect Dis 2006; 194: 725-33. (Pubitemid 44344118)
6. Rosenberg NE, Kamanga G, Phiri S, et al. Detection of acute HIV infection: a field evaluation of the Determine HIV-1/2 Ag/Ab Combo test. J Infect Dis 2011; 205:528-34.
7. Ly TD, Ebel A, Faucher V, Fihman V, Laperche S. Could the new HIV combined p24 antigen and antibody assays replace p24 antigen specific assays? J VirolMethods 2007; 143:86-94. (Pubitemid 46802829)
8. Layne SP, Merges MJ, Dembo M, et al. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. Virology 1992; 189: 695-714.
9. Workman S, Wells SK, Pau CP, et al. Rapid detection of HIV-1 p24 antigen using magnetic immuno-chromatography (MICT). J Virol Methods 2009; 160:14-21.
10. Schupbach J, Tomasik Z, Knuchel M, et al. Optimized virus disruption improves detection of HIV-1 p24 in particles and uncovers a p24 reactivity in patients with undetectable HIV-1 RNA under long-term HAART. J Med Virol 2006; 78:1003-10.
11. Owen SM, Yang C, Spira T, et al. Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United States. J Clin Microbiol 2008; 46:1588-95. (Pubitemid 351657199)
12. Masciotra S, McDougal JS, Feldman J, Sprinkle P, Wesolowski L, Owen SM. Evaluation of an alternative HIV diagnostic algorithm using specimens from seroconversion panels and persons with established HIV infections. J Clin Virol 2011; 52:S17-S22.
13. Fox J, Dunn H, O'Shea S. Low rates of p24 antigen detection using a fourth generation point of care HIV test. Sex Transm Infect 2011;87:178-9.
14. Pandori MW, Louie B, Pilcher C, et al. Assessing the sensitivities of laboratory-based and point-of-care HIV antigen-antibody combination tests using a panel of specimens from recently and acutely infected individuals. http://hivtestingconference.org/PDF/Presentations/Pandori.pdf. Accessed 22 October 2011.
15. Fiscus SA, Pilcher CD, Miller WC, et al. Rapid, real-time detection of acute HIV infection in patients in Africa. J Infect Dis 2007; 195:416-24. (Pubitemid 46146120)
16. Pilcher CD, Fiscus SA, Nguyen TQ, et al. Detection of acute infections during HIV testing in North Carolina. N Engl J Med 2005; 352:1873-83. (Pubitemid 40627813)
17. Patel P, Klausner JD, Bacon OM, et al. Detection of acute HIV infections in high-risk patients in California. J Acquir Immune Defic Syndr 2006; 42:75-9. (Pubitemid 43947949)
18. Stekler JD, Swenson PD, Coombs RW, et al. HIV testing in a high incidence population: is antibody testing alone good enough? Clin Infect Dis 2009; 49:444-53.
19. Patel P, MacKellar D, Simmons P, et al. Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008. Arch Intern Med 2010; 170:66-74.
20. Branson BM. The future of HIV testing. J Acquir Immune Defic Syndr 2010; 55: S102-5.
21. Janssen RS, Satten GA, Stramer SL, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 1998; 280:42-8. (Pubitemid 28414995)
22. Bell SK, Little SJ, Rosenberg ES. Clinical management of acute HIV infection: best practice remains unknown. J Infect Dis 2010; 202(Suppl 2):S278-88.
23. Cohen MS, Shaw GM, McMichael AJ, Haynes BF. Acute HIV-1 infection. N Engl J Med 2011; 364:1943-54.
24. Pilcher CD, Christopoulos KA, Golden M. Public health rationale for rapid nucleic acid or p24 antigen tests for HIV. J Infect Dis 2010; 201:S7-17.
25. Hollingsworth TD, Anderson RM, Fraser C. HIV-1 transmission, by stage of infection. J Infect Dis 2008; 198:687-93.
26. Brenner BG, Roger M, Routy JP, et al. High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis 2007; 195:951-9. (Pubitemid 46452099)
27. Moore ZS, McCoy S, Kuruc J, Hilton M, Leone P. Number of named partners and number of partners newly diagnosed with HIV infection identified by persons with acute versus established HIV infection. J Acquir Immune Defic Syndr 2009; 52: 509-13.
28. Hamlyn E, Jones V, Porter K, Fidler S. Antiretroviral treatment of primary HIV infection to reduce onward transmission. Curr Opin HIV AIDS 2010; 5:283-90.
29. Remien RH, Higgins JA, Correale J, et al. Lack of understanding of acute HIV infection among newly-infected persons-implications for prevention and public health: the NIMH Multisite Acute HIV Infection Study: II. AIDS Behav 2009; 13:1046-53.
30. Ma ZM, Stone M, Piatak M Jr, et al. High specific infectivity of plasma virus from the pre-ramp-up and ramp-up stages of acute simian immunodeficiency virus infection. J Virol 2009; 83:3288-97.
31. Keele BF, Giorgi EE, Salazar-Gonzalez JF, et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci USA 2008; 105:7552-7. (Pubitemid 351830056)